经验药物剂量验证了我们所有人的药物基因组关联
Jan Matthias1,2, Maria J Falaguera3,4, Russ B Altman2,5
1Department of Health Sciences and Technology (D-HEST), ETH Zurich, Zürich, Switzerland.
Clinical and translational science
|November 15, 2025
概括
我们所有人的数据集显示了通过捕捉一些已知的药物基因相互作用,特别是与细胞染色体P450酶的药物基因组研究的潜力. 需要进一步验证才能充分利用其针对个性化医学的能力.
科学领域:
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
- 生物医学信息学 生物医学信息学
背景情况:
- 我们所有人的研究计划提供了多样化的数据集,包括病史,药物剂量和基因组信息.
- 了解药物基因相互作用对于个性化医疗和优化药物疗效至关重要.
- 细胞染色体P450 (CYP450) 酶家族在代谢大多数临床使用的药物中起着至关重要的作用.
研究的目的:
- 评估我们所有人数据集的质量和数量,用于药物基因组 (PGx) 研究.
- 调查在我们所有人的数据集中的电子健康记录中恢复已知的药物基因相互作用的可行性.
- 评估CYP450代谢器表型之间药物剂量的差异.
主要方法:
- 专注于由细胞P450酶家族代谢的61种药物.
- 分析了来自我们所有人研究计划的电子健康记录数据.
- 根据CYP450代谢器表型,确定了药物剂量的显著差异.
主要成果:
- 验证了一些已知的CYP2D6,CYP2C19,CYP2C9和CYP3A5.5的药物基因相互作用.
- 在各种CYP450代谢器表型中观察到药物剂量的显著差异.
- 并没有恢复所有已知的药物基因组相互作用,表明潜在的数据限制或混因素.
结论:
- 我们所有人的数据集显示了识别药物基因组相互作用的潜力.
- 诸如数据噪声,缺乏剂量调整和转换等挑战可能会影响所有已知的相互作用的恢复.
- 需要进一步的研究来完善数据分析方法,并充分利用PGx发现的数据集.
相关概念视频
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
132
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
132
01:24Dosage Regimen: Individualization
146
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
146
01:28Dosage Regimens: Designs and Approaches
227
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
227
01:12Analysis of Population Pharmacokinetic Data
643
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
643
01:15Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
01:20Measurement of Bioavailability: Pharmacodynamic Methods
206
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
206